284 related articles for article (PubMed ID: 11104675)
1. Elevated levels of protein-bound p-hydroxyphenylacetaldehyde, an amino-acid-derived aldehyde generated by myeloperoxidase, are present in human fatty streaks, intermediate lesions and advanced atherosclerotic lesions.
Hazen SL; Gaut JP; Crowley JR; Hsu FF; Heinecke JW
Biochem J; 2000 Dec; 352 Pt 3(Pt 3):693-9. PubMed ID: 11104675
[TBL] [Abstract][Full Text] [Related]
2. p-hydroxyphenylacetaldehyde, an aldehyde generated by myeloperoxidase, modifies phospholipid amino groups of low density lipoprotein in human atherosclerotic intima.
Heller JI; Crowley JR; Hazen SL; Salvay DM; Wagner P; Pennathur S; Heinecke JW
J Biol Chem; 2000 Apr; 275(14):9957-62. PubMed ID: 10744670
[TBL] [Abstract][Full Text] [Related]
3. p-Hydroxyphenylacetaldehyde, the major product of L-tyrosine oxidation by the myeloperoxidase-H2O2-chloride system of phagocytes, covalently modifies epsilon-amino groups of protein lysine residues.
Hazen SL; Gaut JP; Hsu FF; Crowley JR; d'Avignon A; Heinecke JW
J Biol Chem; 1997 Jul; 272(27):16990-8. PubMed ID: 9202012
[TBL] [Abstract][Full Text] [Related]
4. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima.
Hazen SL; Heinecke JW
J Clin Invest; 1997 May; 99(9):2075-81. PubMed ID: 9151778
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, isolation, and characterization of the adduct formed in the reaction of p-hydroxyphenylacetaldehyde with the amino headgroup of phosphatidylethanolamine and phosphatidylserine.
Hazen SL; Heller J; Hsu FF; d'Avignon A; Heinecke JW
Chem Res Toxicol; 1999 Jan; 12(1):19-27. PubMed ID: 9894014
[TBL] [Abstract][Full Text] [Related]
6. Covalent binding of oxidized cholesteryl esters to protein: implications for oxidative modification of low density lipoprotein and atherosclerosis.
Kawai Y; Saito A; Shibata N; Kobayashi M; Yamada S; Osawa T; Uchida K
J Biol Chem; 2003 Jun; 278(23):21040-9. PubMed ID: 12663661
[TBL] [Abstract][Full Text] [Related]
7. Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques.
Leeuwenburgh C; Rasmussen JE; Hsu FF; Mueller DM; Pennathur S; Heinecke JW
J Biol Chem; 1997 Feb; 272(6):3520-6. PubMed ID: 9013599
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical localization of different epitopes of advanced glycation end products in human atherosclerotic lesions.
Sakata N; Imanaga Y; Meng J; Tachikawa Y; Takebayashi S; Nagai R; Horiuchi S; Itabe H; Takano T
Atherosclerosis; 1998 Nov; 141(1):61-75. PubMed ID: 9863539
[TBL] [Abstract][Full Text] [Related]
9. Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. A mechanism for the generation of highly reactive alpha-hydroxy and alpha,beta-unsaturated aldehydes by phagocytes at sites of inflammation.
Anderson MM; Hazen SL; Hsu FF; Heinecke JW
J Clin Invest; 1997 Feb; 99(3):424-32. PubMed ID: 9022075
[TBL] [Abstract][Full Text] [Related]
10. p-Hydroxyphenylacetaldehyde is the major product of L-tyrosine oxidation by activated human phagocytes. A chloride-dependent mechanism for the conversion of free amino acids into reactive aldehydes by myeloperoxidase.
Hazen SL; Hsu FF; Heinecke JW
J Biol Chem; 1996 Jan; 271(4):1861-7. PubMed ID: 8567631
[TBL] [Abstract][Full Text] [Related]
11. In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques.
Imanaga Y; Sakata N; Takebayashi S; Matsunaga A; Sasaki J; Arakawa K; Nagai R; Horiuchi S; Itabe H; Takano T
Atherosclerosis; 2000 Jun; 150(2):343-55. PubMed ID: 10856526
[TBL] [Abstract][Full Text] [Related]
12. p-Hydroxyphenylacetaldehyde, the major product of tyrosine oxidation by the activated myeloperoxidase system can act as an antioxidant in LDL.
Exner M; Alt E; Hermann M; Hofbauer R; Kapiotis S; Quehenberger P; Speiser W; Minar E; Gmeiner B
FEBS Lett; 2001 Feb; 490(1-2):28-31. PubMed ID: 11172805
[TBL] [Abstract][Full Text] [Related]
13. Similarity between naturally occurring modified desialylated, electronegative and aortic low density lipoprotein.
Tertov VV; Sobenin IA; Orekhov AN
Free Radic Res; 1996 Oct; 25(4):313-9. PubMed ID: 8889495
[TBL] [Abstract][Full Text] [Related]
14. Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein.
Requena JR; Fu MX; Ahmed MU; Jenkins AJ; Lyons TJ; Baynes JW; Thorpe SR
Biochem J; 1997 Feb; 322 ( Pt 1)(Pt 1):317-25. PubMed ID: 9078279
[TBL] [Abstract][Full Text] [Related]
15. Identification of alpha-chloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions.
Thukkani AK; McHowat J; Hsu FF; Brennan ML; Hazen SL; Ford DA
Circulation; 2003 Dec; 108(25):3128-33. PubMed ID: 14638540
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of native and naturally occurring multiple modified low density lipoprotein in smooth muscle cells of human aortic intima.
Tertov VV; Orekhov AN
Exp Mol Pathol; 1997; 64(3):127-45. PubMed ID: 9439479
[TBL] [Abstract][Full Text] [Related]
17. The content of lipoperoxidation products in normal and atherosclerotic human aorta.
Tertov VV; Kaplun VV; Mikhailova IA; Suprun IV; Orekhov AN
Mol Cell Biochem; 2001 Sep; 225(1-):21-8. PubMed ID: 11716360
[TBL] [Abstract][Full Text] [Related]
18. Lipoxidation products as biomarkers of oxidative damage to proteins during lipid peroxidation reactions.
Requena JR; Fu MX; Ahmed MU; Jenkins AJ; Lyons TJ; Thorpe SR
Nephrol Dial Transplant; 1996; 11 Suppl 5():48-53. PubMed ID: 9044307
[TBL] [Abstract][Full Text] [Related]
19. Modified low density lipoprotein from diabetic patients causes cholesterol accumulation in human intimal aortic cells.
Sobenin IA; Tertov VV; Koschinsky T; Bünting CE; Slavina ES; Dedov II; Orekhov AN
Atherosclerosis; 1993 Apr; 100(1):41-54. PubMed ID: 8318062
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of acrolein-specific adducts generated during lipid peroxidation-modification of proteins in vitro: identification of N(τ)-(3-propanal)histidine as the major adduct.
Maeshima T; Honda K; Chikazawa M; Shibata T; Kawai Y; Akagawa M; Uchida K
Chem Res Toxicol; 2012 Jul; 25(7):1384-92. PubMed ID: 22716039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
